Daniel Almaguer-Morales
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel Almaguer-Morales has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Alejandro Garza-Alpirez
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Dr. Ignacio Morones Prieto O 3000, Monterrey, 64710. Mexico
1 shared publicationDavid Eugenio Hinojosa-González
Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Dr. Ignacio Morones Prieto O 3000. Mexico
1 shared publication- Jose Alfredo Salinas-Casanova
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Monterrey 64710, Nuevo Leon, Mexico
1 shared publication - Juan Francisco Sánchez-Ávila
Tecnologico de Monterrey Escuela de Medicina y Ciencias de la Salud Monterrey Nuevo Leon Mexico
1 shared publication - Luis Alonso Morales-Garza
Profesor Programa de Medicina Interna, Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Monterrey, México
1 shared publication María Teresa Sánchez-Ávila
Profesor Programa de Medicina Interna, Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Monterrey, México
1 shared publication
Latest Publications
- Open Access
- 1 September 2021
- Published by Elsevier in Annals of Hepatology
- Vol. 24, 100382
P-18 PREVALENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIONS IN PATIENTS WITH CHRONIC LIVER DISEASE: RETROSPECTIVE ANALYSIS FROM A GENERAL HOSPITAL IN MONTERREY, NUEVO LEON, MEXICO
- 1 September 2021
- Published by Elsevier in Annals of Hepatology
- Vol. 24, 100382
Open AccessP-18 PREVALENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIONS IN PATIENTS WITH CHRONIC LIVER DISEASE: RETROSPECTIVE ANALYSIS FROM A GENERAL HOSPITAL IN MONTERREY, NUEVO LEON, MEXICO
- 24 December 2020
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 16 (4) , 337-342
Löfgren Syndrome with Hypercalcemia and Neuroendocrinological Involvement: A Case Report
Background: Sarcoidosis is a systemic inflammatory disease of unknown etiology that can affect virtually any organ. Löfgren syndrome, characterized by erythema nodosum, hilar lymphadenopathy, fever and polyarthritis, represents only 20-30% of the cases of sarcoidosis. Only 2- 10% of the cases feature hypercalcemia. Case: The case of a 42-year-old Hispanic woman with a history of erythema nodosum and three weeks of nausea, emesis, constipation, asthenia, adynamia, polydipsia, and somnolence, concomitant with hypercalcemia, but normal parathyroid hormone (PTH) and 25-hydroxyvitamin D has been presented. The initial diagnostic approach was based upon the suspicion of multiple myeloma or bone metastases; however, further findings of bilateral hilar lymphadenopathy, elevated serum angiotensin-converting enzyme (ACE) and a right inguinal lymphadenomegaly suggested an alternate diagnosis. Biopsy of the latter supported sarcoidosis as the diagnosis. She was successfully treated in the hospital with zoledronic acid and as an outpatient with immunosuppressive therapy. Persistence of a previously undisclosed symptom of oligomenorrhea led to the detection of hyperprolactinemia secondary to hypophyseal infiltration, refractory to immunosuppressive therapy but with an adequate response to cabergoline. Conclusion: This case strays from Löfgren Syndrome’s expected behavior, presenting a more progressive, multisystemic disease. This case report was written in adhThis case strays from Löfgren Syndrome’s expected behavior, presenting a more progressive, multisystemic disease. This case report was written in adherence to the CARE guidelines of 2013 to include information in it.erence to the CARE guidelines of 2013 to include information in it.
- 24 December 2020
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 16 (4) , 337-342
Löfgren Syndrome with Hypercalcemia and Neuroendocrinological Involvement: A Case Report
Background: Sarcoidosis is a systemic inflammatory disease of unknown etiology that can affect virtually any organ. Löfgren syndrome, characterized by erythema nodosum, hilar lymphadenopathy, fever and polyarthritis, represents only 20-30% of the cases of sarcoidosis. Only 2- 10% of the cases feature hypercalcemia. Case: The case of a 42-year-old Hispanic woman with a history of erythema nodosum and three weeks of nausea, emesis, constipation, asthenia, adynamia, polydipsia, and somnolence, concomitant with hypercalcemia, but normal parathyroid hormone (PTH) and 25-hydroxyvitamin D has been presented. The initial diagnostic approach was based upon the suspicion of multiple myeloma or bone metastases; however, further findings of bilateral hilar lymphadenopathy, elevated serum angiotensin-converting enzyme (ACE) and a right inguinal lymphadenomegaly suggested an alternate diagnosis. Biopsy of the latter supported sarcoidosis as the diagnosis. She was successfully treated in the hospital with zoledronic acid and as an outpatient with immunosuppressive therapy. Persistence of a previously undisclosed symptom of oligomenorrhea led to the detection of hyperprolactinemia secondary to hypophyseal infiltration, refractory to immunosuppressive therapy but with an adequate response to cabergoline. Conclusion: This case strays from Löfgren Syndrome’s expected behavior, presenting a more progressive, multisystemic disease. This case report was written in adhThis case strays from Löfgren Syndrome’s expected behavior, presenting a more progressive, multisystemic disease. This case report was written in adherence to the CARE guidelines of 2013 to include information in it.erence to the CARE guidelines of 2013 to include information in it.